0

Qnexa – Combination Weight-Loss Drug Meet Challenges to FDA Approval

 Qnexa – Combination Weight-Loss Drug Meet Challenges to FDA Approval
Vivus Inc has released promising results for their Phase 3 clinical trial CONQUER which was designed to evaluate the safety and efficacy of their new investigational weight loss drug Qnexa. Despite Qnexa’s promising results, the FDA is fearful of unpredictable and dangerous side effects and has been hesitant to approve many weight loss products, including Qnexa...

Post a Comment

Note: Only a member of this blog may post a comment.

 
Top